General Counsel Discussion: 2022 Priorities for Pharmaceutical Industry Associations
Join us in Zürich for our next Women's Life Sciences Network event in which a panel of senior representatives from International, European, and U.S. pharmaceutical industry associations will share and discuss the key priorities for their members in the coming year. The panel will discuss several topics, including:
- Intellectual Property and Incentives for Innovation
- Market Access and Pricing and Reimbursement
- Recent Antitrust Trends
A Q&A session will follow the moderated discussion.
While we very much hope you are able to join us, please note that we may be required to change or cancel all or part of this event due to COVID-19 restrictions and requirements. Attendees will be required to comply with all COVID-19 rules of the venue. We appreciate your understanding.
In light of the COVID-19 pandemic, Sidley is taking precautions to safeguard the well-being of our clients, colleagues, and guests. We encourage you to practice social distancing and follow local guidelines. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days, please refrain from attending this event. We appreciate your cooperation and concern for the health and safety of our guests.
Kristine Peers, General Counsel, EFPIA
Jim Stansel, General Counsel, PhRMA
For more information, please contact Cristina Menendez Ruiz at +32 2 504 6453 or at firstname.lastname@example.org.
Click here to join the Women’s Life Sciences Network LinkedIn Group.
Head of Legal
Global R&D and
Regulatory at Galderma
Sidley Austin LLP